Michael C. Heinrich, Jean-Yves Blay, Ping Chi, Robin Lewis Jones, Cesar Serrano, Neeta Somaiah, Hans Gelderblom, John Raymond Zalcberg, William Reichmann, Kam Sprott, Matthew L. Sherman, Sebastian Bauer, Suzanne George. "INSIGHT: A phase 3, randomized, open-label study of ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib with
            <i>KIT</i>
            exon 11 + 17/18 mutations.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.4_suppl.tps848